Transgene Biotek Ltd to license TrabiORAL to GVK Bio

The Board of directors of Transgene Biotek Ltd has discussed at length on the possibilities and challenges in monetizing TrabiORAL. After detailed deliberations, the Board has approved licensing of TrabiORAL to GVK Bio on terms and conditions of mutual acceptance while retaining the full technology and IP rights with Transgene only.

Shares of TRANSGENE BIOTEK LTD. was last trading in BSE at Rs.3.62 as compared to the previous close of Rs. 3.45. The total number of shares traded during the day was 48325 in over 62 trades.

The stock hit an intraday high of Rs. 3.62 and intraday low of 3.33. The net turnover during the day was Rs. 172924.

Source : Equity Bulls

Keywords